Well-Being, Psychological study: Neuroptimal
Official title Neurofeedback and Well-Being Among People With Co-Occurring Obsessive Compulsive Disorder and Post-traumatic Stress Symptoms
ClinicalTrials.gov ID: NCT07217925
What this study is testing
- What it's testing
- The study will test whether a neurofeedback program can improve overall well‑being and possibly reduce OCD, PTSD, dissociation, and emotional regulation problems.
- Who it's for
- Adults who have trauma‑related symptoms and are on a wait list for OCD‑specific therapy at an outpatient clinic.
- What's involved
- Participants will receive neurofeedback sessions and complete questionnaires about their well‑being and symptoms. They may also have other routine clinic visits.
- Time commitment
- The study lasts several weeks, with multiple neurofeedback sessions and follow‑up assessments scheduled during that time.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- being a client placed on the clinic waitlist to receive exposure-response prevention for OCD symptoms at the Anxiety and OCD Treatment Center of Ann...
- having self-reported symptoms of OCD;
- having post-traumatic stress symptoms as indicated by a score of 3 or higher on the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) screening measure;
- being age 18+.
- being a citizen of the United States of America -
You likely can't join if
- a lifetime history of significant untreated mental illness (not currently treated schizophrenia, schizoaffective disorder, bipolar disorder, or...
- a documented history of epilepsy;
- lifetime history of any head injury with loss of consciousness;
- current exposure domestic or intimate partner violence or otherwise state that their current living conditions are unsafe;
- current experiences of psychosis or suicidality within the last six months;
- currently taking, or in the past month has taken benzodiazepines, narcotic drugs, or cannabis;
See the full eligibility criteria
- being a client placed on the clinic waitlist to receive exposure-response prevention for OCD symptoms at the Anxiety and OCD Treatment Center of Ann Arbor, in Ann Arbor, MI.
- having self-reported symptoms of OCD;
- having post-traumatic stress symptoms as indicated by a score of 3 or higher on the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) screening measure;
- being age 18+.
- being a citizen of the United States of America -
- a lifetime history of significant untreated mental illness (not currently treated schizophrenia, schizoaffective disorder, bipolar disorder, or substance use disorder) or neurological or pervasive developmental disorder;
- a documented history of epilepsy;
- lifetime history of any head injury with loss of consciousness;
- current exposure domestic or intimate partner violence or otherwise state that their current living conditions are unsafe;
- current experiences of psychosis or suicidality within the last six months;
- currently taking, or in the past month has taken benzodiazepines, narcotic drugs, or cannabis;
- currently pregnant
- engagement in self-harming behaviors in the last 3 months that required medical attention;
- lack of competence to understand or consent to the study procedures;
- lack of fluency in written and spoken English. -
The study team makes the final eligibility decision.
Where it is enrolling
- Detroit, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Detroit, Michigan, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.